Nuveen’s Precision BioSciences DTIL Stock Holding History

Nuveen’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Buy	+32,287	New	+$227K	﹤0.01%	3556
2022 Q2	–	Sell	-17,010	Closed	-$1.56M	–	3311
2022 Q1	$1.56M	Buy	17,010 +1,179	+7%	+$160K	﹤0.01%	2629
2021 Q4	$3.52M	Buy	15,831 +483	+3%	+$135K	﹤0.01%	2293
2021 Q3	$5.31M	Buy	15,348 +9,865	+180%	+$3.34M	﹤0.01%	2175
2021 Q2	$2.06M	Sell	5,483 -356	-6%	-$107K	﹤0.01%	2696
2021 Q1	$1.81M	Buy	5,839 +730	+14%	+$256K	﹤0.01%	2663
2020 Q4	$1.28M	Sell	5,109 -1,727	-25%	-$423K	﹤0.01%	2717
2020 Q3	$1.26M	Buy	6,836 +28	+0.4%	+$5.57K	﹤0.01%	2587
2020 Q2	$1.7M	Buy	6,808 +633	+10%	+$139K	﹤0.01%	2407
2020 Q1	$1.12M	Buy	6,175 +1,222	+25%	+$320K	﹤0.01%	2471
2019 Q4	$2.06M	Buy	4,953 +4,500	+993%	+$1.41M	﹤0.01%	2408
2019 Q3	$114K	Hold	453	–	–	﹤0.01%	3158
2019 Q2	$180K	Buy	+453	New	+$182K	﹤0.01%	3189

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Nuveen's DTIL Position: Q2 2026 in Review

Nuveen opened a new position in Precision BioSciences (DTIL) in Q2 2026: 32,287 shares worth $254K. The stake represents ﹤0.01% of the portfolio and ranks #3556 among its holdings. This is a return to the name: Nuveen previously reported a position in DTIL as recently as Q1 2022.

Nuveen first reported a position in DTIL in Q2 2019 and has held it in 13 quarters since. The position peaked at $5.31M in Q3 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Nuveen held 32,287 shares of Precision BioSciences worth $254K as of Q2 2026.
Precision BioSciences was a new Nuveen position in Q2 2026.
Precision BioSciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3556 holding.
Nuveen first reported a position in Precision BioSciences in Q2 2019 and has held it in 13 quarters since.
Nuveen's Precision BioSciences position peaked at $5.31M in Q3 2021.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.